Endonovo Therapeutics Inc (ENDV) - Product Pipeline Analysis, 2018 Update

Published by Global Data on 27th December 2018 | Ref: 1127987 | This Report Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Enterprise License
$750 | Single User
$1500 | Site License
$2250 | Enterprise License



Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Its Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. Endonovo Therapeutics’ pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders such as acute concussions, post-concussion syndrome, ischemic heart disease, traumatic brain injury and multiple sclerosis. The company’s Electroceuticals are electronic devices designed to affect biological systems to alleviate or mitigate symptomatology and pathology. Endonovo Therapeutics is headquartered in Woodland Hills, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Endonovo Therapeutics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Endonovo Therapeutics Inc Company Overview 5

Endonovo Therapeutics Inc Company Snapshot 5

Endonovo Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Endonovo Therapeutics Inc – Pipeline Analysis Overview 8

Endonovo Therapeutics Inc - Key Facts 8

Endonovo Therapeutics Inc - Major Products and Services 9

Endonovo Therapeutics Inc Pipeline Products by Development Stage 10

Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status 12

Endonovo Therapeutics Inc Pipeline Products Overview 14

Bioelectronic Device - Acute Kidney Injury 14

Bioelectronic Device - Acute Kidney Injury Product Overview 14

Bioelectronic Device - Acute Myocardial Infarction 15

Bioelectronic Device - Acute Myocardial Infarction Product Overview 15

Bioelectronic Device - Fulminant Liver Failure 16

Bioelectronic Device - Fulminant Liver Failure Product Overview 16

Bioelectronic Device - Urinary Incontinence 17

Bioelectronic Device - Urinary Incontinence Product Overview 17


DSF-rTMS Product Overview 18

Multi-Coil Transcranial Magnetic Stimulation System 19

Multi-Coil Transcranial Magnetic Stimulation System Product Overview 19

Non-Invasive Electroceutical Device - CKD 20

Non-Invasive Electroceutical Device - CKD Product Overview 20

Non-Invasive Electroceutical Device - CLI 21

Non-Invasive Electroceutical Device - CLI Product Overview 21

Non-Invasive Electroceutical Device - CLI Clinical Trial 22

Non-Invasive Electroceutical Device - NASH 23

Non-Invasive Electroceutical Device - NASH Product Overview 23

SofPulse 24

SofPulse Product Overview 24

SofPulse Clinical Trial 25

Endonovo Therapeutics Inc - Key Competitors 26

Endonovo Therapeutics Inc - Key Employees 27

Endonovo Therapeutics Inc - Locations And Subsidiaries 28

Head Office 28

Recent Developments 29

Endonovo Therapeutics Inc, Recent Developments 29

Jun 14, 2018: Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical Therapy 29

May 09, 2018: Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical SofPulse 29

May 01, 2018: Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients 30

Apr 19, 2018: Flowsion Wins Horizon 2020 SME Instrument Grant for Automatic Glucose Control in Intensive Care Medicine 30

Feb 12, 2018: Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device 31

Feb 01, 2018: Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction 31

Jan 22, 2018: Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema 32

Jan 16, 2018: Endonovo Therapeutics Provides Corporate Update and 2018 Outlook 33

Oct 13, 2017: Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive Electroceutical 34

Sep 26, 2017: Endonovo Therapeutics Provides Update on Pre-Clinical Studies 35

Appendix 36

Methodology 36

About GlobalData 39

Contact Us 39

Disclaimer 39

Additional Details


Global Data

Publisher Information


1127987 | GDME509447PD

Number of Pages


Report Format


This report is published by Global Data

Download Free Report Summary PDF

Endonovo Therapeutics Inc (ENDV) - Product Pipeline Analysis, 2018 Update [Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.